ReviewNature communications2026
Beyond petrochemicals: challenges and opportunities in industrial-scale biomanufacturing.
Review in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Closing the Loop with Gates: A Scale-up-Gated Design-Build-Test-Learn Framework for Industrial Fermentation.Microorganisms · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Biomanufacturing offers a sustainable alternative to petrochemical manufacturing by harnessing engineered microorganisms to convert renewable feedstocks into diverse value-added products. Systems metabolic engineering has driven its advancement, enabling rational design of microbial strains with enhanced performance and robustness. Despite these achievements, large-scale commercialisation remains limited, highlighting the persistent gap between laboratory success and industrial deployment. We examine the challenges and opportunities in advancing biomanufacturing towards industrial implementation through two cases, succinic acid and polyhydroxyalkanoates, that exemplify products nearing, yet not fully reaching, commercial maturity. Finally, we discuss how integrating artificial intelligence with systems metabolic engineering can accelerate sustainable biomanufacturing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.